Abstract:Cancer-specific metabolic changes support the anabolic needs of the rapidly growing tumor, maintain a favorable redox balance, and help cells adapt to microenvironmental stresses like hypoxia and nutrient deprivation. Radiation is extensively applied in a large number of cancer treatment protocols but despite its curative potential, radiation resistance and treatment failures pose a serious problem. Metabolic control of DNA integrity and genomic stability can occur through multiple processes, encompassing cell cycle regulation, nucleotide synthesis, epigenetic regulation of gene activity, and antioxidant defenses. Given the important role of metabolic pathways in oxidative damage responses, it is necessary to assess the potential for tumor-specific radiosensitization by novel metabolism-targeted therapies. Additionally, there are opportunities to identify molecular and functional biomarkers of vulnerabilities to combination treatments, which could then inform clinical decisions. Here, we present a curated list of metabolic pathways in the context of ionizing radiation responses. Glutamine metabolism influences DNA damage responses by mechanisms such as synthesis of nucleotides for DNA repair or of glutathione for ROS detoxification. Repurposed oxygen consumption inhibitors have shown promising radiosensitizing activity against murine model tumors and are now in clinical trials. Production of 2-hydroxy glutarate by isocitrate dehydrogenase1/2 neomorphic oncogenic mutants interferes with the function of α-ketoglutarate-dependent enzymes and modulates Ataxia Telangiectasia Mutated (ATM) signaling and glutathione pools. Radiation-induced oxidative damage to membrane phospholipids promotes ferroptotic cell loss and cooperates with immunotherapies to improve tumor control. In summary, there are opportunities to enhance the efficacy of radiotherapy by exploiting cell-inherent vulnerabilities and dynamic microenvironmental components of the tumor.

Targeting E3 Ubiquitin Ligases to Sensitize Cancer Radiation Therapy

Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance.

Radiosensitization of Cancer Cells by Inactivation of Cullin-Ring E3 Ubiquitin Ligases

The Mechanism of Ubiquitination or Deubiquitination Modifications in Regulating Solid Tumor Radiosensitivity

DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer

Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization

Targeting Epithelial-to-Mesenchymal Transition in Radioresistance: Crosslinked Mechanisms and Strategies

Receptor tyrosine kinase signaling in cancer radiotherapy and its targeting for tumor radiosensitization

Radiation-induced Tumor Immune Microenvironments and Potential Targets for Combination Therapy

Highlights on molecular targets for radiosensitization of breast cancer cells: Current research status and prospects

Novel Insights Into E3 Ubiquitin Ligase in Cancer Chemoresistance

Improving the Efficacy of Tumor Radiosensitization Through Combined Molecular Targeting

Targeting the Ubiquitin Signaling Cascade in Tumor Microenvironment for Cancer Therapy

Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer

Application of nanomedicine in radiotherapy sensitization

Empowering Radiotherapy: Harnessing Nanomedicines to Enhance Radiation Response and Boost Antitumor Efficacy

Emerging strategies to target cancer metabolism and improve radiation therapy outcomes

Emerging Strategies of Nanomaterial‐Mediated Tumor Radiosensitization

Targeting E3 Ubiquitin Ligases for Cancer Therapy

Molecular mechanisms of sensitivity and resistance to radiotherapy

Targeting the Ubiquitin Pathway for Cancer Treatment